These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31807998)

  • 1. ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.
    Tremolizzo L; Lizio A; Santangelo G; Diamanti S; Lunetta C; Gerardi F; Messina S; La Foresta S; Riva N; Falzone Y; Filippi M; Woolley SC; Sansone VA; Siciliano M; Ferrarese C; Appollonio I;
    Neurol Sci; 2020 Apr; 41(4):835-841. PubMed ID: 31807998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS.
    Murphy J; Ahmed F; Lomen-Hoerth C
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):24-30. PubMed ID: 25301548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods.
    Simon N; Goldstein LH
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):1-11. PubMed ID: 30585510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and behavioral status in Japanese ALS patients: a multicenter study.
    Watanabe Y; Raaphorst J; Izumi Y; Yoshino H; Ito S; Adachi T; Takigawa H; Masuda M; Atsuta N; Adachi Y; Isose S; Arai K; Yokota O; Oda M; Ogino M; Ichikawa H; Hasegawa K; Kimura H; Shimizu T; Aiba I; Yabe H; Kanba M; Kusumi K; Aoki T; Hiroe Y; Watanabe H; Nishiyama K; Nomoto M; Sobue G; Beeldman E; Hanajima R; Nakashima K;
    J Neurol; 2020 May; 267(5):1321-1330. PubMed ID: 31955246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Affecting Performance on a Screening Tool in Persons with Amyotrophic Lateral Sclerosis.
    Stierwalt J; Stierwalt JAG; Clark H; Burda A; Benavidez Kiley H; Collins E; Kortemeyer M; Miller E; Peckenschneider G; Schieltz E; Shah Y; Simon K
    Semin Speech Lang; 2024 Jun; 45(3):228-241. PubMed ID: 38565200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecological validity of performance-based cognitive screeners in amyotrophic lateral sclerosis: preliminary evidence.
    Aiello EN; Torre S; Solca F; Curti B; De Luca G; Gendarini C; Cocuzza A; Colombo E; Maranzano A; Verde F; Morelli C; Messina S; Doretti A; Silani V; Ticozzi N; Poletti B
    Neurol Sci; 2024 Nov; 45(11):5319-5325. PubMed ID: 38904901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.
    Huynh W; Ahmed R; Mahoney CJ; Nguyen C; Tu S; Caga J; Loh P; Lin CS; Kiernan MC
    Expert Rev Neurother; 2020 Mar; 20(3):281-293. PubMed ID: 32031423
    [No Abstract]   [Full Text] [Related]  

  • 8. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).
    Woolley SC; York MK; Moore DH; Strutt AM; Murphy J; Schulz PE; Katz JS
    Amyotroph Lateral Scler; 2010 May; 11(3):303-11. PubMed ID: 20433413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS).
    Christodoulou G; Gennings C; Hupf J; Factor-Litvak P; Murphy J; Goetz RR; Mitsumoto H
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):482-488. PubMed ID: 27121545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test.
    Turon-Sans J; Gascon-Bayarri J; Reñé R; Rico I; Gámez C; Paipa A; Povedano M
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):221-7. PubMed ID: 26726932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the extent of reliability and validity evidence for screening tools for cognitive and behavioral change in people with ALS? A systematic review.
    Didcote L; Vitoratou S; Al-Chalabi A; Goldstein LH
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):437-451. PubMed ID: 38415696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients.
    Woolley S; Goetz R; Factor-Litvak P; Murphy J; Hupf J; Garofalo DC; Lomen-Hoerth C; Andrews H; Heitzman D; Bedlack R; Katz J; Barohn R; Sorenson E; Oskarsson B; Filho AF; Kasarskis E; Mozaffar T; Nations S; Swenson A; Koczon-Jaremko A; Christodoulou G; Mitsumoto H
    Behav Neurol; 2018; 2018():5969137. PubMed ID: 30515252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS).
    Poletti B; Solca F; Carelli L; Madotto F; Lafronza A; Faini A; Monti A; Zago S; Calini D; Tiloca C; Doretti A; Verde F; Ratti A; Ticozzi N; Abrahams S; Silani V
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):489-498. PubMed ID: 27219526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores.
    Siciliano M; Trojano L; Trojsi F; Greco R; Santoro M; Basile G; Piscopo F; D'Iorio A; Patrone M; Femiano C; Monsurrò M; Tedeschi G; Santangelo G
    Neurol Sci; 2017 Jun; 38(6):1059-1068. PubMed ID: 28332040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen.
    Bakker LA; Schröder CD; Spreij LA; Verhaegen M; De Vocht J; Van Damme P; Veldink JH; Visser-Meily JMA; van den Berg LH; Nijboer TCW; van Es MA
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):19-27. PubMed ID: 30314420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinimetrics of the cognitive section of the Italian ALS Cognitive Behavioral Screen (ALS-CBS™).
    Aiello EN; Greco LC; La Tona A; Solca F; Torre S; Carelli L; Pain D; Radici A; Lizio A; Casiraghi J; Cerri F; Brugnera A; Compare A; Woolley S; Murphy J; Tremolizzo L; Appollonio I; Verde F; Silani V; Ticozzi N; Lunetta C; Sansone VA; Poletti B
    Neurol Sci; 2023 Apr; 44(4):1243-1249. PubMed ID: 36547779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis.
    De Marchi F; Sarnelli MF; Solara V; Bersano E; Cantello R; Mazzini L
    Acta Neurol Scand; 2019 May; 139(5):438-445. PubMed ID: 30712314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients.
    Aiello EN; Solca F; Torre S; Colombo E; Maranzano A; De Lorenzo A; Patisso V; Treddenti M; Curti B; Morelli C; Doretti A; Verde F; Ferrucci R; Barbieri S; Ruggiero F; Priori A; Silani V; Ticozzi N; Poletti B
    Eur Neurol; 2024; 87(2):79-83. PubMed ID: 38643758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcultural validation of the ALS-CBS Cognitive Section for the Brazilian population.
    Branco LM; Zanao T; De Rezende TJ; Casseb RF; Balthazar MF; Woolley SC; França MC
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):60-67. PubMed ID: 27534257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.